Company Info
| Phone: | (301) 556-9900 |
| Year Established: | 1998 |
| Ticker: | PGEN |
| Exchange: | NASDAQ |
Contacts
| Primary: | Helen Sabzevari, PhD President & CEO |
| Other: | Donald Lehr, JD CLO Rutul R. Shah COO Harry Thomasian Jr. CFO |
Company Description
Precigen, formerly Intrexon & Genomatix, is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapie.
